ICUI insider trading
NasdaqGS HealthcareICU MEDICAL INC/DE — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ICU MEDICAL INC/DE
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Company website: www.icumed.com
ICUI insider activity at a glance
FilingIQ has scored 1,358 insider transactions for ICUI since Jan 13, 2015. The most recent filing in our index is dated May 13, 2026.
Across the full history, 10 open-market purchases
and 470 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ICUI insider trades is 59.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ICUI Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ICUI?
- FilingIQ tracks 1,358 Form 4 insider transactions for ICUI (ICU MEDICAL INC/DE), covering filings from Jan 13, 2015 onwards. 97 of those were filed in the last 90 days.
- Are ICUI insiders net buyers or net sellers?
- Across the full Form 4 history for ICUI, 10 transactions (1%) were open-market purchases and 470 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ICUI insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ICUI in?
- ICU MEDICAL INC/DE (ICUI) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $3.74B.
Methodology & sources
Every ICUI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.